Anastrozole (Arimidex), letrozole (Femara), and exemestane (Aromasin) are members of the third generation of aromatase inhibitors that has now replaced aminoglutethimide (Cytadren), the progestins, and tamoxifen
Anne Hamilton, MBBS
Advertisement
Articles by Anne Hamilton, MBBS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
ASCO 2026: Key Genitourinary Oncology Trials to Watch For
2
ASCO 2026: The Presentations That May Shape The Future of Multiple Myeloma
3
What Are The Top Lymphoma Abstracts at ASCO 2026?
4
Sac-TMT Combo Improves PFS vs Pembrolizumab in NSCLC
5